In Wyoming, Compound Laws tracks 19 compounds: 5 legal to sell at retail, 4 restricted, 0 in a gray area, 4 illegal, 1 not yet verified, and 5 whose status varies by product form. Verified through October 22, 2026.
1d261613699de43dSection 1. W.S. 11-51-101(a)(iii), (vi), (vii) and by creating a new paragraph (viii), 11-51-102(b), 11-51-103 by creating a new subsection (f), 11-51-104(a)(intro), (iii), (b), (d) and by creating a new subsection (e), 35-7-1014(d)(xxi) and 35-7-1063(b) are amended to read: 11-51-101. Definitions. (a) As used in this chapter: (iii) 'Hemp' or 'hemp product' means all parts, seeds and varieties of the plant cannabis sativa l., whether growing or not, or a product, derivative, extract, cannabinoid, isomer, acid, salt or salt of isomer made from that plant with no synthetic substance and with a THC concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis when using post-decarboxylation or another similarly reliable testing method; (vi) 'Process' means converting hemp into another product that contains no synthetic substance and that contains no more than three-tenths of one percent (0.3%) THC on a dry weight basis when using post-decarboxylation or another similarly reliable testing method; (vii) 'THC' means: (A) Tetrahydrocannabinol, the psychoactive component of the cannabis plant, with the scientific name trans-delta 9-tetrahydrocannabinol; (B) Psychoactive analogs of tetrahydrocannabinol as defined by W.S. 14-3-301(a)(xi); (C) Any psychoactive structural, optical or geometric isomers of tetrahydrocannabinol. (viii) 'Synthetic substance' means any synthetic THC, synthetic cannabinoid or any other drug or psychoactive substance. 11-51-102. Hemp as agricultural crop; use of hemp. (b) Notwithstanding the requirements of this chapter, the possession, purchase, sale, transportation and use of hemp and hemp products by any person is allowable except as provided in W.S. 11-51-103(f) and 14-3-310. 11-51-103. Licensing; prohibited activities. (f) No person or licensee shall: (i) Produce, process or sell hemp or hemp products containing more than three-tenths of one percent (0.3%) THC on a dry weight basis when using post-decarboxylation or another similarly reliable testing method; (ii) Add, alter, insert or otherwise include any synthetic substance into hemp or hemp products produced, processed or sold in accordance with this chapter. 11-51-104. Enforcement; fees; penalties. (a) The department shall perform inspections and provide chemical sampling and analysis of production or processing activities by licensees to determine compliance with this chapter. The department may require verification of effective disposal by licensees of hemp or hemp products that contain synthetic substances or that contain in excess of three-tenths of one percent (0.3%) THC on a dry weight basis. (b) Except as provided in subsection (e) of this section, any licensee who violates any provision of this chapter or any regulation promulgated pursuant to this chapter shall be subject to a corrective action plan. The corrective action plan may include reporting requirements, additional inspections, suspension of a license, steps necessary to restore a license, requirements related to disposal of hemp or hemp products that contain in excess of three-tenths of one percent (0.3%) THC on a dry weight basis or providing notice of the violation to the licensee's known creditors. (d) If any person has three (3) or more violations of this chapter or any regulation promulgated pursuant to this chapter within five (5) years, the department shall revoke the license and the person shall be ineligible for licensure under this article chapter for five (5) years. (e) Any person who violates this chapter by producing, processing or selling hemp or hemp products containing any synthetic substance shall be ineligible for licensure under this chapter. 35-7-1014. Substances included in Schedule I. (d) Hallucinogenic substances.-Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term 'isomer' includes the optical, position and geometric isomers): (xxi) Tetrahydrocannabinols; naturally occurring or synthetic equivalents of the substances contained in the plant or in the resinous extractives of Cannabis, sp. and/or naturally occurring or synthetic substances, derivatives and their isomers with similar chemical structure and pharmacological activity such as the following: delta 1 cis or trans tetrahydrocannabinol and their optical isomers; delta 6 cis or trans tetrahydrocannabinol and their optical isomers; delta 8 cis or trans tetrahydrocannabinol and their optical isomers; delta to the 3, 4 cis or trans tetrahydrocannabinol and its optical isomers. Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered; 35-7-1063. Exceptions to provisions. (b) As used in this section: (i) 'Hemp' or 'hemp product' means all parts, seeds and varieties of the plant cannabis sativa l. or a product made from that plant with no synthetic substances and with a trans-delta 9-tetrahydrocannabinol (THC) concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis; (ii) 'Synthetic substance' means as defined by W.S. 11-51-101(a)(viii); (iii) 'THC' means as defined by W.S. 11-51-101(a)(vii). Section 2. The department of agriculture and the commissioner of drugs and substances control shall promulgate all rules necessary to implement this act. Section 3. (a) Except as provided in subsection (b) of this section, this act is effective immediately upon completion of all acts necessary for a bill to become law as provided by Article 4, Section 8 of the Wyoming Constitution. (b) Section 1 of this act is effective July 1, 2024.
75cdc96ed3b2d8e411-51-101(a)(iii) ["Hemp" means] "all parts, seeds and varieties of the plant cannabis sativa l., whether growing or not" [...] "with a THC concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis" [measured] "on a dry weight basis when using post-decarboxylation or another similarly reliable testing method". (vii) [THC includes] "Tetrahydrocannabinol, the psychoactive component of the cannabis plant" [and psychoactive analogs and isomers]. 11-51-103(f) [No person shall] (i) [produce, process or sell hemp or hemp products over 0.3% THC]; (ii) [add] "any synthetic substance into hemp or hemp products." [Section 1 effective July 1, 2024.] [Bracketed spans summarized.]
a08d2e77889180e635-7-1014. Substances included in Schedule I. (a) The controlled substances listed in this section are included in Schedule I. Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. (b) Opiates.-Unless specifically excepted or unless listed in another schedule, any of the following opiates, including the isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (i) Acetylmethadol; (ii) Repealed By Laws 1997, ch. 151, § 2. (iii) Allylprodine; (iv) Alphacetylmethadol (except levo- alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); (v) Alphameprodine; (vi) Alphamethadol; (vii) Alpha-methylfentanyl (N-[1-(alpha-methylbeta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine); (viii) Benzethidine; (ix) Betacetylmethadol; (x) Betameprodine; (xi) Betamethadol; (xii) Betaprodine; (xiii) Clonitazene; (xiv) Dextromoramide; (xv) Diampromide; (xvi) Diethylthiambutene; (xvii) Difenoxin; (xviii) Dimenoxadol; (xix) Dimepheptanol; (xx) Dimethylthiambutene; (xxi) Dioxaphetyl butyrate; (xxii) Dipipanone; (xxiii) Ethylmethylthiambutene; (xxiv) Etonitazene; (xxv) Etoxeridine; (xxvi) Furethidine; (xxvii) Hydroxypethidine; (xxviii) Ketobemidone; (xxix) Levomoramide; (xxx) Levophenacylmorphan; (xxxi) Morpheridine; (xxxii) Noracymethadol; (xxxiii) Norlevorphanol; (xxxiv) Normethadone; (xxxv) Norpipanone; (xxxvi) Phenadoxone; (xxxvii) Phenampromide; (xxxviii) Phenomorphan; (xxxix) Phenoperidine; (xl) Piritramide; (xli) Proheptazine; (xlii) Properidine; (xliii) Propiram; (xliv) Racemoramide; (xlv) Tilidine; (xlvi) Trimeperidine; (xlvii) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl- 2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (xlviii) Alpha-methylthiofentanyl (N-[1-methyl-2-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (xlix) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2- phenethyl)-4-piperidinyl]-N-phenylpropanamide); (l) Beta-hydroxy-3-methylfentanyl (other name: N-[1- (2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N- phenylpropanamide); (li) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)- 4-piperidyl]-N-phenylpropanamide); (lii) 3-Methylthiofentanyl (N-[3-methyl-1-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (liii) MPPP (1-methyl-4-phenyl-4- propionoxypiperidine); (liv) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl] propanamide); (lv) PEPAP (1-(-2-phenethyl)-4-phenyl-4- acetoxypiperidine); (lvi) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4- piperidinyl]-propanamide). (c) Opium derivatives.-Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation: (i) Acetorphine; (ii) Acetyldihydrocodeine; (iii) Benzylmorphine; (iv) Codeine methylbromide; (v) Codeine-N-Oxide; (vi) Cyprenorphine; (vii) Desomorphine; (viii) Dihydromorphine; (ix) Drotebanol; (x) Etorphine (except hydrochloride salt); (xi) Heroin; (xii) Hydromorphinol; (xiii) Methyldesorphine; (xiv) Methyldihydromorphine; (xv) Morphine methylbromide; (xvi) Morphine methylsulfonate; (xvii) Morphine-N-Oxide; (xviii) Myrophine; (xix) Nicocodeine; (xx) Nicomorphine; (xxi) Normorphine; (xxii) Pholcodine; (xxiii) Thebacon. (d) Hallucinogenic substances.-Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers): (i) 4-bromo-2, 5-dimethoxyamphetamine; some trade or other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA; (ii) 2, 5-dimethoxyamphetamine; some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA; (iii) 4-methoxyamphetamine; some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxy-amphetamine; PMA; (iv) 5-methoxy-3,4-methylenedioxy amphetamine; (v) 4-methyl-2, 5-dimethoxyamphetamine; some trade and other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"; and "STP"; (vi) 3,4-methylenedioxy amphetamine; (vii) 3,4,5-trimethoxy amphetamine; (viii) Bufotenine; some trade and other names: 3-(beta-dimethy-laminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine; (ix) Diethyltryptamine; some trade and other names: N,N-diethyltryptamine; DET; (x) Dimethyltryptamine; some trade or other names: DMT; (xi) Ibogaine; some trade and other names: 7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole; tabernanthe iboga; (xii) Lysergic acid diethylamide; (xiii) Marihuana; (xiv) Mescaline; (xv) Parahexyl; some trade or other names; 3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl; (xvi) Peyote; meaning all parts of the plant presently classified botanically as Lophophora Williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts; (xvii) N-ethyl-3-piperidyl benzilate; (xviii) N-methyl-3-piperidyl benzilate; (xix) Psilocybin; (xx) Psilocyn; (xxi) Tetrahydrocannabinols; naturally occurring or synthetic equivalents of the substances contained in the plant or in the resinous extractives of Cannabis, sp. and/or naturally occurring or synthetic substances, derivatives and their isomers with similar chemical structure and pharmacological activity such as the following: delta 1 cis or trans tetrahydrocannabinol and their optical isomers; delta 6 cis or trans tetrahydrocannabinol and their optical isomers; delta 8 cis or trans tetrahydrocannabinol and their optical isomers; delta to the 3, 4 cis or trans tetrahydrocannabinol and its optical isomers. Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered; (xxii) Ethylamine analog of phencyclidine; some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl) ethylamine, cyclohexamine, PCE; (xxiii) Pyrrolidine analog of phencyclidine; some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP; (xxiv) Thiophene analog of phencyclidine; some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP; (xxv) Alpha-ethyltryptamine; some trade or other names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3- (2-aminobutyl) indole; --ET; and AET; (xxvi) 4-Bromo-2,5-dimethoxyphenethylamine; some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1- aminoethane; alpha-desmethyl DOB; 2C-B, nexus; (xxvii) 2,5-Dimethoxy-4-ethylamphetamine; some trade or other names: DOET; (xxviii) 3,4-Methylenedioxymethamphetamine (MDMA); (xxix) 3,4-Methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA); (xxx) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl- 3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA); (xxxi) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some other names: TCPy; (xxxii) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7), its optical isomers, salts and salts of isomers; (xxxiii) Alpha-methyltryptamine; (other name: AMT); (xxxiv) 5-methoxy-N,N-diisopropyltryptamine; (other name: 5-MeO-DIPT), its isomers, salts and salts of isomers; (xxxv) Salvinorin A; (xxxvi) 3,4-Methylenedioxymethcathinone (other names: Methylone); (xxxvii) 3,4–Methylenedioxypyrovalerone (MDPV); (xxxviii) 4–Methylmethcathinone (other names Mephedrone); (xxxix) 3–Methoxymethcathinone; (xl) 3–Fluoromethcathinone; (xli) 4–Fluoromethcathinone; (xlii) Synthetic cannabinoids as follows: (A) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-210; (B) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU- 211; (C) Any compound structurally derived from 3-(1- napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1- napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or naphthylideneindene by substitution at the nitrogen atom of the indole ring, pyrrole ring or 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring, pyrrole ring or indene ring to any extent, and whether or not substituted in the naphthyl or phenyl ring to any extent; (D) Repealed By Laws 2012, Ch. 29, § 2. (E) Any compound containing a 2-(3- hydroxycyclohexyl)phenol structure with substitution at the 5- position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not substituted in the cyclohexyl ring to any extent; (F) 2,3-Dihydro-5-methyl-3-(4- morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone; some trade or other names: WIN 55,212-2; (G) [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone]; other names: XLR-11; (H) [(1-pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone]; other names: UR-144; (J) 1-pentyl-8-quinolinyl ester-1H-indole-3- carboxylic acid; other names: PB-22; (K) 1-(5-fluoropentyl)-8-quinolinyl ester-1H- indole-3-carboxylic acid; other names: 5F-PB-22; (M) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H- indazole-3-carboxamide; other names: AKB48; (N) N-((3s,5s,7s)-adamantan-1-yl)-1-(5- fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48; (O) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB- FUBINACA; (P) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA; (Q) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA; (R) N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1- (5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB- PINACA; (S) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB- PINACA; (T) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB– CHMINACA; (U) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha len-1-yl)methanone; other names: THJ–2201; (W) 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester; other names: BB-22. (xliii) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine; other names: 2C-E; (xliv) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine; other names: 2C-D; (xlv) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine; other names: 2C-C; (xlvi) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine; other names: 2C-I; (xlvii) 2-[4-(ethylthio)-2,5- dimethoxyphenyl]ethanamine; other names: 2C-T-2; (xlviii) 2-[4-(isopropylthio)-2,5- dimethoxyphenyl]ethanamine; other names: 2C-T-4; (xlix) 2-(2,5-dimethoxyphenyl)ethanamine; other names: 2C-H; (l) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other names: 2C-N; (li) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine; other names: 2C-P; (lii) 4-bromo-2,5-dimethoxy-N-[(2- methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe; (liii) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe; (liv) 4-iodo-2,5-dimethoxy-N-[(2- methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe; (lv) 3,4-methylenedioxy-N-ethylcathinone; (other names: ethylone). (e) Depressants.-Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (i) Mecloqualone; (ii) Methaqualone; (iii) Gamma-hydroxybutyric (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate). (f) Stimulants.-Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its optical, positional, and geometric isomers, salts and salts of isomers: (i) Fenethylline; (ii) N-ethylamphetamine; (iii) Aminorex; some other names: aminoxaphen; 2- amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2- oxazolamine; (iv) Cathinone; some trade or other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2- aminopropiophenone, and norephedrone; (v) Methcathinone; some other names: 2-(methylamino)- propiophenone; alpha-(methylamino)propiophenone; 2- (methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone; N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers; (vi) (()Cis-4-methylaminorex ((()cis-4,5-dihydro-4- methyl-5-phenyl-2-oxazolamine); (vii) N,N-dimethylamphetamine (also known as N,N- alpha-trimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine); (viii) N-Benzylpiperazine; (some other names: BZP, 1- benzylpiperazine), its optical isomers, salts and salts of isomers; (ix) 4-methyl-N-ethylcathinone; other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one; (x) 4-methyl-alpha-pyrrolidinopropiophenone; other names: 4-MePPP; MePPP; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one; (xi) Alpha-pyrrolidinopentiophenone; other names: alpha-PVP; alpha-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pent an-1-one; (xii) Butylone; other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one; (xiii) Pentedrone; other names: alpha-methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one; (xiv) Pentylone; other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one; (xv) Naphyrone; other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one; (xvi) Alpha-pyrrolidinobutiophenone; other names: alpha-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one. (g) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture or preparation which contains any quantity of the following substances: (i) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers; (ii) N-[1-(2-thienyl)methyl-4-piperidyl]-N- phenylpropanamide (thenylfentanyl), its optical isomers, salts and salts of isomers.
3d0f541c7928104735-7-2201. Definitions. (a)(i) "Adulterated" means the addition of a controlled substance, a synthesized alkaloid or semi-synthesized alkaloid into a kratom product; (vi) "Kratom product" means a food or dietary supplement that consists of or contains any part of the kratom leaf, kratom leaf extract or any kratom alkaloid, kratom constituent or kratom metabolite. "Kratom product" shall not include any synthesized alkaloid or semi-synthesized alkaloid; (viii) "Semi-synthesized alkaloid" ... exposed to chemicals or processes that would confer a structural change ... including but not limited to oxidation, reduction and ring opening and closing ... 35-7-2202. (a) A person is guilty of a violation if the person: (i) ... sells or offers for sale a kratom product: (A) That is adulterated; (B) To a person less than twenty-one (21) years of age; (C) That contains a level of 7-hydromitragynine [sic] in the alkaloid fraction that is greater than two percent (2%) of the alkaloid composition ...; (D) confection/candy/child-appealing; or (E) combustible or intended for vaporization. (ii) labeling requirements (incl. per-serving mitragynine + 7-hydroxymitragynine declarations). (iv) manufactures/packages/labels a kratom product that: (A) Contains synthesized alkaloids or semi-synthesized alkaloids; or (B) Has a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than two percent (2%) ... (b) misdemeanor, up to 1 yr / $1,000.
2aa3e531354f4d41**§ 35-7-1014(d) (hallucinogen chapeau)** — "(d) Hallucinogenic substances.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term 'isomer' includes the optical, position and geometric isomers):" — Wyo. Stat. § 35-7-1014(d), https://law.justia.com/codes/wyoming/title-35/chapter-7/article-10/section-35-7-1014/ (MIRROR: Justia, 2025). Psilocyn and psilocybin are listed; 4-HO-MET is not. **§ 35-7-1002 (definitions — no analog term)** — the definitions section defines "Controlled substance" as "a drug, substance, or immediate precursor in schedules I through V of article III" (§ 35-7-1002(a)(iv)) and contains **no** definition of "controlled substance analog," "analogue," or "substantially similar." — Wyo. Stat. § 35-7-1002, https://law.justia.com/codes/wyoming/title-35/chapter-7/article-10/section-35-7-1002/ (MIRROR: Justia, 2025).
7a08ccf815e7eb2d11-51-101. Definitions. (a) As used in this chapter: (i) "Corrective action plan" means a plan the department develops in consultation with a licensee to correct any violation of this chapter; (ii) "Disposal" means activities to alter or treat hemp or hemp products that contain an amount of THC in excess of the amount authorized in this chapter to ensure that the THC is reduced to bring the hemp or hemp product into compliance with this chapter or, if compliance is not attainable, that the THC is rendered inaccessible; (iii) "Hemp" or "hemp product" means all parts, seeds and varieties of the plant cannabis sativa l., whether growing or not, or a product, derivative, extract, cannabinoid, isomer, acid, salt or salt of isomer made from that plant with no synthetic substance and with a THC concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis when using post-decarboxylation or another similarly reliable testing method; (iv) "Licensee" means a person licensed under this chapter to produce, process or test hemp; (v) "Produce" means all acts necessary to produce and market hemp including, without limitation, planting, cultivating, harvesting, cloning, producing seeds, handling, transporting and selling; (vi) "Process" means converting hemp into another product that contains no synthetic substance and that contains no more than three-tenths of one percent (0.3%) THC on a dry weight basis when using post-decarboxylation or another similarly reliable testing method; (vii) "THC" means: (A) Tetrahydrocannabinol, the psychoactive component of the cannabis plant, with the scientific name trans-delta 9-tetrahydrocannabinol; (B) Psychoactive analogs of tetrahydrocannabinol as defined by W.S. 14-3-301(a)(xi); (C) Any psychoactive structural, optical or geometric isomers of tetrahydrocannabinol. (viii) "Synthetic substance" means any synthetic THC, synthetic cannabinoid or any other drug or psychoactive substance.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap